Off-the-Shelf immune cells take on Hard-to-Treat lymphomas
Disease control
Recruiting now
This early-phase trial is testing a combination of donor natural killer (NK) cells and the drug mogamulizumab in 12 patients with relapsed or refractory cutaneous T-cell lymphoma or adult T-cell leukemia/lymphoma. The NK cells are grown in the lab and given 'off the shelf' to boo…
Phase: PHASE1 • Sponsor: John Reneau • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC